Breast cancer drug 'could save many lives'

A drug that lowers oestrogen levels in women with hormone-sensitive breast cancer could save many lives a year if adopted for widespread treatment, new research has shown.

Switching from the gold-standard breast cancer treatment tamoxifen to the new drug exemestane after two or three years resulted in death rates falling by 17%.